Chan H H, Leung R S, Ying S Y, Lai C F, Kono T, Chua J K, Ho W S
Division of Dermatology, Department of Medicine, University of Hong Kong, Hong Kong.
Dermatol Surg. 2000 Nov;26(11):1000-6. doi: 10.1046/j.1524-4725.2000.0260111000.x.
Studies on the use of Q-switched alexandrite (QS alex) and QS Nd:YAG lasers in the treatment of nevus of Ota were limited to case reports and small series. There was no study that looked at the complication rate of these systems.
To retrospectively study the complication rate of nevus of Ota patients that were treated with QS alex laser, QS Nd:YAG laser, or a combination of both.
The study was performed in a teaching hospital and a private hospital, where 513 patients with nevus of Ota had been treated since 1993. The 171 patients with 211 treatment sites were evaluated retrospectively following treatment with QS alex laser only (n = 58), QS Nd:YAG laser (n = 105) only, or a combination of both systems (n = 48). Patients were called back to be interviewed and examined by two independent clinicians to look for evidence of complications.
Of the treatment sites, 15. 3% had hypopigmentation, 2.9% had hyperpigmentation, and texture changes and scarring were seen in 2.9% and 1.9%, respectively. The combined treatment group was associated with a significantly higher risk of complications. Thirteen patients had recurrence of their nevus after complete or near-complete clearance with laser treatment.
Hypopigmentation is common after the use of QS laser for lightening of nevus of Ota. This particularly applies when alternate treatment with QS alex and QS Nd:YAG is used. Recurrence is an important issue and must be taken into consideration, especially when children are treated.
关于调Q紫翠宝石(QS alex)激光和调Q钕:钇铝石榴石(QS Nd:YAG)激光治疗太田痣的研究仅限于病例报告和小样本系列研究。尚无研究关注这些治疗系统的并发症发生率。
回顾性研究接受QS alex激光、QS Nd:YAG激光或两者联合治疗的太田痣患者的并发症发生率。
本研究在一家教学医院和一家私立医院进行,自1993年以来,共有513例太田痣患者在此接受治疗。对仅接受QS alex激光治疗(n = 58)、仅接受QS Nd:YAG激光治疗(n = 105)或两种系统联合治疗(n = 48)的171例患者的211个治疗部位进行回顾性评估。召回患者接受两名独立临床医生的访谈和检查,以寻找并发症证据。
在治疗部位中,15.3%出现色素减退,2.9%出现色素沉着,质地改变和瘢痕形成分别占2.9%和1.9%。联合治疗组的并发症风险显著更高。13例患者在激光治疗完全或接近完全清除太田痣后出现复发。
使用QS激光治疗太田痣后色素减退很常见。当交替使用QS alex和QS Nd:YAG激光治疗时尤其如此。复发是一个重要问题,必须予以考虑,尤其是在治疗儿童患者时。